| Disease | A RANDOMIZED, CONTROLLED, DOUBLE-BLIND TRIAL WAS PERFORMED ON 102 MALE AND FEMALE VOLUNTEERS TO DETERMINE WHETHER REACTION TIME, ALERTNESS AND CONCENTRATION MIGHT BE IMPAIRED BY TREATMENT WITH A NATIVE VALERIAN ROOT EXTRACT (VRE). THE EFFECT WAS
FIRST EXAMINED THE MORNING AFTER A SINGLE EVENING DOSE OF VRE(600 MG LI 156) VS. FLUNITRAZEPAM(FNZ) (1 MG) AND PLACEBO (PL)(TRIAL SECTION A), AND THEN AFTER TWO WEEKS OF EVENING ADMINISTRATION OF VRE(600 MG LI 156) VS. PL(TRIAL SECTION B).
THE PRIMARY CRITERION WAS THE MEDIAN OF REACTION TIME(MRT) MEASURED WITH THE VIENNA DETERMINATION TEST. SECONDARY CRITERIA WERE COGNITRONES (ALERTNESS TEST), TRACKING TEST(TWO-HANDED CO-ORDINATION), SLEEP QUALITY(VIS-A, VIS-M), FURTHER VDT
PARAMETERS, AND SAFETY CRITERIA. IT IS CONCLUDED THAT NEITHER SINGLE NOR REPEATED EVENING ADMINISTRATIONS OF 600 MG OF VRE HAVE A RELEVANT NEGATIVE IMPACT ON REACTION TIME, ALERTNESS AND CONCENTRATION THE MORNING AFTER INTAKE. |